Global Market Study on Sterile Injectable Drugs: Cancer Application Segment to Significantly Contribute to the Growth of the Global Market During 2017 - 2025


Sterile Injectable Drugs Market
  • Published On : Dec-2017 |
  • Pages : 218 Pages |
  • Format :

This Persistence Market Research (PMR) report features the ‘Sterile Injectable Drugs Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)’. The report objective is to offer updates on the ongoing market trends and information regarding market opportunities in the global sterile injectable drugs market. This report by Persistence Market Research (PMR) examines sterile injectable drugs market for the period 2012–2025. The primary objective of the report is to offer insights into developments in the sterile injectable drugs market that are significantly transforming global businesses and enterprises.

The Sterile Injectable Drugs market segmented as follows:

  • Sterile Injectable Drugs Market, by molecule type
  • Sterile Injectable Drugs Market, by drug type
  • Sterile Injectable Drugs Market, by application
  • Sterile Injectable Drugs Market, by route of administration
  • Sterile Injectable Drugs Market, by distribution channel
  • Sterile Injectable Drugs Market, by region

The report uncovers the global sterile injectable drugs market performance concerning revenue contribution from various segments and their scenario across regions in the globe. This section also comprises of PMR analysis of key trends, drivers, challenges, and opportunities, which are influencing the growth of the global sterile injectable drugs market. Impact analysis of the key growth drivers and restraints are included in this report to provide clients with decision-making insights.

The sterile injectable drugs market report provides an overview of the market. This section also underlines factors influencing the growth of sterile injectable drugs market along with detailing of the key trends, drivers, challenges, and opportunities. Distinguishing features of the report includes a list of major vendors manufacturing workstations, drivers, and restraints regional impact analysis, and competitive dashboard. Furthermore, PMR provides a competitive landscape to the companies and their strategic developments.

The next section of the research report analyzes the market based on molecule type and presents the forecast in terms of value for the next eight years. Molecule type covered in the report include: 

  • Small Molecules
  • Large Molecules

The subsequent section of the research report analyzes the market based on drug type and presents the forecast in terms of value for the next eight years. Drug type covered in the report include:

  • Monoclonal Antibodies (mAbs)
  • Cytokines
  • Insulin
  • Peptide hormones
  • Vaccines
  • Immunoglobulins
  • Blood Factors
  • Peptide antibiotics
  • Others

The following section of the research report analyzes the market based on application and presents the forecast in terms of value for the next eight years. Application covered in the report include:

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Musculoskeletal
  • CNS
  • Infections
  • Others

The next section of the research report analyzes the market based on route of administration and presents the forecast in terms of value for the next eight years. Route of administration covered in the report include:

  • Intravenous
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Others

The subsequent section of the research report analyzes the market based on distribution channel and presents the forecast in terms of value for the next eight years. Distribution channel covered in the report include:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The report focuses on the growth trends of the sterile injectable drugs market by regions namely, North America, Latin America, Europe, Asia-Pacific, Middle East & Africa. It provides an outlook for 2017–2025 & sets the forecast for sterile injectable drugs market. The market research report discusses regional trends contributing to the growth of the Sterile Injectable Drugs market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Regions covered in the report include:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific (APAC)
    • Japan
    • China
    • Australia and New Zealand
    • India
    • ASEAN
    • Rest of APAC
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • North Africa
    • Rest of the Middle East and Africa

Also, we have considered the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global sterile injectable drugs market. An analysis of absolute dollar opportunity and incremental opportunity is conducted for primary segments of this report. Absolute dollar opportunity is usually overlooked while forecasting the market. However, it is the most critical factor for analysing the level of opportunities that a manufacturer can look to achieve, as well as to identify potential resources from a sales and delivery perspective.

In the final section of the sterile injectable drugs market report, ‘Competitive Landscape' section is included to provide a detailed analysis with a dashboard view, to access the key differentiators among the competitor firms. Detailed profiles of major manufacturing companies is included with company-specific long-term and short-term strategies, company profiles are equipped with their product offerings and recent developments in the sterile injectable drugs market. This section can give the reader an idea of the new strategies that he/she can devise and implement with a view to gain competitive advantage.

Introduction

The intravenous administration of medicines into the body of a patient with a needle or catheter is prescribed by physicians and administered by trained professionals and nurses. It is used when oral medication is not effective for the treatment of diseases. It reduces the time spent by patients in hospitals, nursing homes and clinics. It includes continuous and slow administration of drugs, antibiotics, nutrients and other fluids into the veins on a daily, weekly, or monthly basis, depending on the patient’s condition.

Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body. These preparations are administered by injection, infusion or implantation in the body with help of needle, syringe or implantable devices. Sterile injectable drugs market is highly regulated with rigid guidelines owing to safety, quality and sterility requirements. Drugs and biological preparations which are available in sterile, injectable form are considered for this study. Sterile injectable drugs is an effective and safe alternative against conventional hospitalization for treatment of diseases as it provides a faster recovery from diseases. Sterile injectable drugs is employed in the treatment of diseases which are unresponsive to oral medication, such as cancer, cardiovascular diseases, musculoskeletal, diabetes and other diseases. It is also recommended in the treatment of diabetes and other infections. Sterile injectable drugs improves medication adherence and reduces unplanned hospitalization.

Market Value and Forecast

The global sterile injectable drugs estimated to be worth US$ 383.1 Mn by 2017 end and is expected to expand at a CAGR of 6.9% over the forecast period of 2017–2025. The global market for sterile injectable drugs has been witnessing an upward growth. In 2017, it reflected a valuation of more than US$ 380 Mn and is anticipated to touch a value higher than US$ 650 Mn by the end of the year of assessment.

Market Dynamics

Growth of the global sterile injectable drugs is primarily driven by increasing demand for novel drug delivery systems, rising prevalence of chronic diseases, increasing public private partnerships and also rising awareness towards the use of sterile injectable drugs. The rising demand for injectable drug delivery is driving injectable drugs development and growth of sterile injectable drugs in health management associations.  However, high operational costs, discontinuation of products, monopoly in manufacturing & sourcing, lack of standard usage guidelines & trained manpower and lack of proper treatment/diagnosis options for diseases are some of the factors expected to hamper the growth of the global sterile injectable drugs market over the forecast period.

Cardiovascular diseases segment to run at a higher pace than other segments in the application category

Based on application, the market has been segmented into,

By Application

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Musculoskeletal
  • CNS
  • Infections
  • Others

global sterile injectable drugs market

The cardiovascular diseases segment is projected to grow at a higher rate throughout the period of assessment. It is expected to register a CAGR of 9.2% during the 2017-2025 timeline and is estimated to touch a valuation more than US$ 100 Mn by the end of the year of assessment. Cardiovascular diseases segment along with the Cancer, Diabetes segments is expected to present better investment opportunities for prospect investors in sterile injectable drugs market. The others application segment held a highest revenue share of approximately 31% in 2016 and is expected to dominate throughout the forecast period, registering higher CAGR as compared to other segments.

Company Profiles

  • Baxter International Inc.
  • Sanofi
  • GlaxoSmithKline plc.
  • AstraZeneca Plc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • GILEAD SCIENCES, INC.
  • Johnson & Johnson Services, Inc.
  • hameln group gmbh
  • Others
Back To Top